Showing 1 - 8 results of 8 for search 'Minshan Chen', query time: 0.12s
Refine Results
-
1
Current Status and Future of Multidisciplinary Team in Hepatocellular Carcinoma by Jinbin CHEN, Yaojun ZHANG, Minshan CHEN
Published 2025-06-01Get full text
Article -
2
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Qianyu Wang, Li Hu, Li Hu, Li Hu, Xiaoxian Sima, Xiaoxian Sima, Xiaoxian Sima, Juncheng Wang, Juncheng Wang, Juncheng Wang, Dandan Hu, Dandan Hu, Dandan Hu, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yizhen Fu, Yizhen Fu, Yizhen Fu
Published 2024-12-01Get full text
Article -
3
NR4A2 attenuates early brain injury after intracerebral hemorrhage by promoting M2 microglial polarization via TLR4/TRAF6/NF-κB pathway inhibition by Di Hu, Cheng Huang, Ling Tang, Jiawen Lei, Jiaqi Wang, Wenzheng Hu, Minshan Chen, Siyuan Song, Lin Lu, Pingyi Xu
Published 2025-06-01Get full text
Article -
4
Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Weijie Wu, Weijie Wu, Weijie Wu, Zhiwen Hu, Zhiwen Hu, Zhiwen Hu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zili Hu, Zili Hu, Zili Hu, Yangxun Pan, Yangxun Pan, Yangxun Pan, Juncheng Wang, Juncheng Wang, Juncheng Wang, Jinbin Chen, Jinbin Chen, Jinbin Chen, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Minshan Chen, Minshan Chen, Minshan Chen, Dandan Hu, Dandan Hu, Dandan Hu
Published 2024-11-01Get full text
Article -
5
Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma by Lichang Huang, Yujie Xu, Na Liu, Hailong Chen, Zichao Wu, Qijiong Li, Minqiang Lu, Wei Wei, Yaojun Zhang, Minshan Chen, Li Xu, Ming Shi, Zhicheng Lai
Published 2025-05-01Get full text
Article -
6
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment by Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen
Published 2024-09-01Get full text
Article -
7
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity by Haiyan Zhang, Xiaojing Luo, Wei Yang, Zhiying Wu, Zhicong Zhao, Xin Pei, Xue Zhang, Chonghao Chen, Josh Haipeng Lei, Qingxia Shi, Qi Zhao, Yanxing Chen, Wenwei Wu, Zhaolei Zeng, Huai-Qiang Ju, Miaozhen Qiu, Jun Liu, Bin Shen, Minshan Chen, Jianjun Chen, Chu-Xia Deng, Rui-Hua Xu, Jiajie Hou
Published 2024-11-01Get full text
Article -
8
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021 by Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Yue Han, Gong Li, Xinyu Bi, Chunyi Hao, Xiaodong Wang, Jun Zhou, Chaoliu Dai, Feng Wen, Jingdong Zhang, Ruibao Liu, Tao Li, Lei Zhao, Zuoxing Niu, Tianfu Wen, Qiu Li, Hongmei Zhang, Xiaoming Chen, Minshan Chen, Ming Zhao, Yajin Chen, Jun Yu, Jie Shen, Xiangchen Li, Lianxin Liu, Zhiyong Huang, Wei Zhang, Feng Shen, Weiping Zhou, Zhengang Yuan, Jian Zhai, Ningling Ge, Yongjun Chen, Huichuan Sun, Jianqiang Cai
Published 2025-06-01Get full text
Article